TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 110 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | -33.3% | 25 | -28.6% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 35 | -28.6% | 0.00% | – |
| Q2 2019 | $4,000 | -33.3% | 49 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 49 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -71.4% | 49 | -65.5% | 0.00% | – |
| Q3 2018 | $14,000 | -12.5% | 142 | 0.0% | 0.00% | – |
| Q2 2018 | $16,000 | -33.3% | 142 | -42.5% | 0.00% | – |
| Q1 2018 | $24,000 | -36.8% | 247 | -31.2% | 0.00% | -100.0% |
| Q4 2017 | $38,000 | +8.6% | 359 | +13.2% | 0.00% | 0.0% |
| Q3 2017 | $35,000 | -36.4% | 317 | -35.6% | 0.00% | 0.0% |
| Q2 2017 | $55,000 | -12.7% | 492 | -9.4% | 0.00% | 0.0% |
| Q1 2017 | $63,000 | +8.6% | 543 | -2.2% | 0.00% | 0.0% |
| Q4 2016 | $58,000 | -6.5% | 555 | -0.4% | 0.00% | 0.0% |
| Q3 2016 | $62,000 | -21.5% | 557 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $79,000 | – | 557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |